Rallybio is coming off an active year in 2020, when it moved its home office to New Haven’s Gold Building at 234 Church St., and began human testing on its first drug, which treats a rare condition causing uncontrolled bleeding in newborns. It also brought its lifetime venture capital fundraising to $182 million.
Paul S. Parker, director of the UConn TIP, says the company has been one of the most successful fundraisers in the incubator’s history.